PGEN Precigen Inc
Price (delayed)
$1.5
Market cap
$441.06M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.47
Enterprise value
$417.05M
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases
Highlights
PGEN's quick ratio has soared by 64% YoY
PGEN's gross profit is up by 31% since the previous quarter
PGEN's net income is down by 32% year-on-year but it is up by 10% since the previous quarter
Precigen's EPS has decreased by 21% YoY but it has increased by 15% QoQ
PGEN's equity has dropped by 67% year-on-year and by 30% since the previous quarter
Precigen's revenue has decreased by 37% YoY
Key stats
What are the main financial stats of PGEN
Market
Valuations
Earnings
Shares outstanding
294.04M
Market cap
$441.06M
Enterprise value
$417.05M
Price to earnings (P/E)
N/A
Price to book (P/B)
11.41
Price to sales (P/S)
102.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
106.25
Revenue
$3.93M
Gross profit
-$342,000
Operating income
-$135.03M
Net income
-$126.24M
EBIT
-$128.02M
EBITDA
-$123.5M
Free cash flow
-$76.7M
Per share
Balance sheet
Liquidity
EPS
-$0.47
EPS diluted
-$0.47
Free cash flow per share
-$0.29
Book value per share
$0.13
Revenue per share
$0.01
TBVPS
$0.45
Total assets
$145.27M
Total liabilities
$78.54M
Debt
$5.5M
Equity
$38.51M
Working capital
$80.9M
Debt to equity
0.14
Current ratio
4.76
Quick ratio
4.6
Net debt/EBITDA
0.19
Margins
Efficiency
Dividend
EBITDA margin
-3,146.4%
Gross margin
-8.7%
Net margin
-3,216.2%
Operating margin
-3,440.2%
Return on assets
-115.6%
Return on equity
-215.7%
Return on invested capital
-374.1%
Return on capital employed
-103.5%
Return on sales
-3,261.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PGEN stock price
How has the Precigen stock price performed over time
Intraday
-5.66%
1 week
7.91%
1 month
-12.28%
1 year
7.14%
YTD
33.93%
QTD
0.67%
Financial performance
How have Precigen's revenue and profit performed over time
Revenue
$3.93M
Gross profit
-$342,000
Operating income
-$135.03M
Net income
-$126.24M
Gross margin
-8.7%
Net margin
-3,216.2%
PGEN's operating margin has plunged by 115% YoY but it is up by 3.1% from the previous quarter
Precigen's net margin has plunged by 109% YoY but it has increased by 9% from the previous quarter
Precigen's revenue has decreased by 37% YoY
Precigen's operating income has decreased by 35% YoY but it has increased by 4.1% from the previous quarter
Growth
What is Precigen's growth rate over time
Valuation
What is Precigen stock price valuation
P/E
N/A
P/B
11.41
P/S
102.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
106.25
Precigen's EPS has decreased by 21% YoY but it has increased by 15% QoQ
PGEN's P/B is 86% above its last 4 quarters average of 6.5 and 66% above its 5-year quarterly average of 7.3
PGEN's equity has dropped by 67% year-on-year and by 30% since the previous quarter
PGEN's P/S is 92% below its 5-year quarterly average of 1324.3 but 45% above its last 4 quarters average of 74.9
Precigen's revenue has decreased by 37% YoY
Efficiency
How efficient is Precigen business performance
The ROA has plunged by 138% YoY but it has grown by 8% from the previous quarter
Precigen's return on sales has shrunk by 112% YoY but it has increased by 9% QoQ
PGEN's return on equity is down by 21% since the previous quarter
The ROIC has grown by 20% from the previous quarter
Dividends
What is PGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PGEN.
Financial health
How did Precigen financials performed over time
The company's total assets is 85% higher than its total liabilities
PGEN's current ratio has surged by 192% since the previous quarter and by 59% year-on-year
PGEN's total liabilities has soared by 180% from the previous quarter and by 141% YoY
Precigen's debt is 86% less than its equity
PGEN's debt to equity has soared by 133% YoY and by 40% from the previous quarter
PGEN's equity has dropped by 67% year-on-year and by 30% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.